机构

• 上海药物研究所 [3]

采集方式

• OAI收割 [3]

内容类型

• 期刊论文 [3]

发表日期

• 2024 [1]
• 2019 [2]

学科主题

筛选

浏览/检索结果: 共3条，第1-3条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序作者升序作者降序 Amide alkaloids and neolignans from Piper hongkongense and their inhibitory activities of PCSK9 expression 期刊论文  OAI收割 FITOTERAPIA, 2024, 卷号: 175, 页码: 7 作者:  Hu, Xianggang;  Chen, Tong;  Guo, Pengju;  Wang, Qing;  Ding, Aoxue   |  收藏  |  浏览/下载：23/0  |  提交时间：2024/06/27 Piper hongkongense  piper  Amide alkaloids  Neolignans  Inhibitory activities of PCSK9 expression   Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9, 期号: 6, 页码: 1216-1230 作者:  Wu, Chenglin;  Xi, Cong;  Tong, Junhua;  Zhao, Jing;  Jiang, Hualiang   |  收藏  |  浏览/下载：48/0  |  提交时间：2020/07/01 PCSK9  Tetrahydroprotoberberine derivatives  Low-density lipoprotein cholesterol  Lipid-lowering  PCSK9 expression  Low-density lipoprotein receptor  Total cholesterol  Hyperlipidemia hamster   designsynthesisandbiologicalevaluationofnoveltetrahydroprotoberberinederivativesthpbsasproproteinconvertasesubtilisinkexintype9pcsk9modulatorsforthetreatmentofhyperlipidemia 期刊论文  OAI收割 actapharmaceuticasinicab, 2019, 卷号: 9, 期号: 6, 页码: 1216 作者:  Wu Chenglin;  Xi Cong;  Tong Junhua;  Zhao Jing;  Jiang Hualiang   |  收藏  |  浏览/下载：16/0  |  提交时间：2020/07/01 DOPAMINE D-1  BERBERINE  EXPRESSION  INHIBITORS  IDENTIFICATION  CHOLESTEROL  MUTATIONS  LDLR  PCSK9  Tetrahydroprotoberberine derivatives  Low-density lipoprotein cholesterol  Lipid-lowering  PCSK9 expression  Low-density lipoprotein receptor  Total cholesterol  Hyperlipidemia hamster